It’s no surprise that the average American would want a magic pill (or in this case, an injectable) for losing weight and Zepbound seems to be one of those miracle drugs.
Zepbound is a prescription weight loss medicine. It contains tirzepatide that helps manage Type 2 Diabetes, promote weight loss, as well as treat moderate-to-severe obstructive sleep apnea (OSA).
The manufacturer of Zepbound is Eli Lilly and Company a global pharmaceutical company headquartered in Indianapolis, Indiana, USA. Eli Lilly is well known for producing diabetes medications like Insulin, Trulicity, and Mounjaro. In the fourth quarter of 2024, Eli Lilly reported a $13.53 billion revenue, a 45% increase from the same period in the previous year.
Atraxia Law specializes in helping patients who have suffered medication-induced injuries from products such as Zepbound (tirzepatide), so if you believe you’re a victim of its side effects, we encourage you to reach out to us for legal assistance. We can look into your case and let you know if you meet the eligibility criteria. To file a Zepbound claim:
if you developed gastroparesis, bowel obstruction, or NAION after being treated with Zepbound, we encourage you to contact our team of professionals, who can help you determine whether you are entitled to monetary compensation. To assess your case, we will need evidence of you undergoing Zepbound treatment and your medical records with your diagnosis.
In December 2024, about 1,300 people filed a lawsuit against Zepbound manufacturer Eli Lilly and Company.
The plaintiffs are alleging that the active agent tirzepatide used in Zepbound is causing multiple side effects that have led to severe and probably permanent injuries.